Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-11-18 Sale | 2022-11-22 4:07 pm | Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, CHIEF FINANCIAL OFFICER | 65,000 | $11.02 | $716,242 | 384,714 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-11-20 Tax Withholding | 2022-11-22 4:07 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, CHIEF FINANCIAL OFFICER | 25,057 | $10.85 | 384,714 (Direct) | View |
| 2022-08-19 Tax Withholding | 2022-08-23 7:00 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, CHIEF FINANCIAL OFFICER | 25,676 | $9.34 | 473,507 (Direct) | View |
| 2022-07-25 Option Award | 2022-07-27 6:56 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, CHIEF FINANCIAL OFFICER | 20,000 | $0 | 499,183 (Direct) | View |
| 2022-05-20 Tax Withholding | 2022-05-24 7:17 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, CHIEF FINANCIAL OFFICER | 3,365 | $8.74 | 479,183 (Direct) | View |
| 2022-02-18 Tax Withholding | 2022-02-23 6:29 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, CHIEF FINANCIAL OFFICER | 25,973 | $9.61 | 481,285 (Direct) | View |
| 2021-12-02 Option Award | 2021-12-06 7:53 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, Chief Financial Officer | 340,000 | $0 | 507,258 (Direct) | View |
| 2021-11-19 Tax Withholding | 2021-11-23 8:22 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, CHIEF FINANCIAL OFFICER | 1,350 | $8.36 | 167,258 (Direct) | View |
| 2021-08-20 Tax Withholding | 2021-08-24 6:55 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, Chief Financial Officer | 17,464 | $14.05 | 167,380 (Direct) | View |
| 2021-05-20 Tax Withholding | 2021-05-24 6:10 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, Chief Financial Officer | 942 | $17.8 | 184,844 (Direct) | View |
| 2021-02-20 Tax Withholding | 2021-02-23 6:07 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, Chief Financial Officer | 3,984 | $18.79 | 184,704 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-10 5:43 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, Chief Financial Officer | 65,000 | $0 | 188,688 (Direct) | View |
| 2020-08-20 Tax Withholding | 2020-08-24 6:24 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, Chief Financial Officer | 4,323 | $18.22 | 123,135 (Direct) | View |
| 2020-07-27 Option Award | 2020-07-29 5:05 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, Chief Financial Officer | 20,000 | $0 | 127,458 (Direct) | View |
| 2020-02-20 Tax Withholding | 2020-02-24 7:08 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, Chief Financial Officer | 7,060 | $25.9 | 106,490 (Direct) | View |
| 2020-02-03 Option Award | 2020-02-05 6:58 pm | N/A N/A | Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, Chief Financial Officer | 63,550 | $0 | 113,550 (Direct) | View |
| 2019-07-01 Option Award | 2019-07-03 6:05 pm | N/A 2029-06-30 | Theravance Biopharma Inc. | TBPH | Hindman Andrew A. SVP, Chief Financial Officer | 310,000 | $0 | 310,000 (Direct) | View |